ADCT ADC Therapeutics SA Common Shares
NYSE · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$1,13
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,7852-Wochen-Tief
$4,9852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$144M
P/E (TTM)
-1.9
EPS (TTM)
$-0.58
Umsatz (TTM)
$80M
Ihre Abzeichen
52W-Spanne
$1–$5
Analystenbewertung
STRONG BUY
Kursziel
$3
P/E
-1.9
ROE
45.3%
Nettogewinnmarge
-121.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ADCT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.13
Marktkapitalisierung (MRQ)
$144M
P/E (TTM)
-1.9
EPS (TTM)
$-0.58
Umsatz (TTM)
$80M
ROE (TTM)
45.3%
Verschuldungsgrad (MRQ)
-0.0
52W-Spanne
$1–$5
ADCT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$81M2022-12-31 → 2025-12-31
EPS$-1.122022-12-31 → 2025-12-31
Freier Cashflow$-141M2020-12-31 → 2025-12-31
Nettogewinnmarge-121.8%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ADCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.95-Jahres-Durchschnitt ≈-1.7 | ≈-1.7 | · | · | |
| P/S (TTM) | 1.85-Jahres-Durchschnitt ≈3.4 | ≈3.4 | · | · | |
| K/B (MRQ) | -0.65-Jahres-Durchschnitt ≈-1.4 | ≈-1.4 | · | · | |
| EV / EBITDA | 0.9 | · | · | · | |
| Kurs / FCF (TTM) | -1.45-Jahres-Durchschnitt ≈-1.9 | ≈-1.9 | · | · | |
| Kurs / Cashflow (TTM) | -1.45-Jahres-Durchschnitt ≈-2.0 | ≈-2.0 | · | · | |
| EV / Revenue (EV / Umsatz) | -1.4 | · | · | · | |
| EV / FCF | 0.8 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ADCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -125.1%5-Jahres-Durchschnitt ≈-190.8% | ≈-190.8% | · | · | |
| EBITDA Margin (EBITDA-Marge) | -149.3%5-Jahres-Durchschnitt ≈-190.8% | ≈-190.8% | · | · | |
| Vorgewinnmarge (TTM) | -122.3%5-Jahres-Durchschnitt ≈-225.1% | ≈-225.1% | · | · | |
| Nettogewinnmarge (TTM) | -121.8%5-Jahres-Durchschnitt ≈-247.8% | ≈-247.8% | · | · | |
| ROA (TTM) | -32.3%5-Jahres-Durchschnitt ≈-43.1% | ≈-43.1% | · | · | |
| ROE (TTM) | 45.3%5-Jahres-Durchschnitt ≈32.8% | ≈32.8% | · | · | |
| ROIC | 66.9%5-Jahres-Durchschnitt ≈-3.7% | ≈-3.7% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ADCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -0.0 | · | · | · | |
| Liquiditätsgrad (MRQ) | 3.05-Jahres-Durchschnitt ≈5.0 | ≈5.0 | · | · | |
| Quick Ratio | 3.75-Jahres-Durchschnitt ≈4.3 | ≈4.3 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ADCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 14.8%5-Jahres-Durchschnitt ≈-16.7% | ≈-16.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -27.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ADCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.2 | ≈0.2 | · | · | |
| Inventory Turnover (Lagerumschlag) | 1.85-Jahres-Durchschnitt ≈0.6 | ≈0.6 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$432.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
38.0%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-0.11 | $-0.22 | 49.1% |
| 31. März 2026 | Mai 12, 2026 | $-0.13 | $-0.22 | 40.7% |
| 31. Dezember 2025 | $-0.04 | $-0.27 | 85.4% | |
| 30. September 2025 | $-0.30 | $-0.37 | 18.7% | |
| 30. Juni 2025 | $-0.38 | $-0.48 | 21.4% | |
| 31. März 2025 | $-0.36 | $-0.41 | 12.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $81M | $71M | $70M | $210M | |
| Cost of Revenue | $6M | $6M | $3M | $3M | |
| R&D Expense | $104M | $110M | $127M | $186M | |
| SG&A Expense | $37M | $42M | $48M | $74M | |
| Operating Expenses | $203M | $201M | $236M | $333M | |
| Operating Income | $-121M | $-131M | $-166M | $-123M | |
| Interest Expense | · | $50M | $46M | $37M | |
| Interest Income | $9M | $12M | $11M | $3M | |
| Other Non-op | $23M | $12M | $6M | $53M | |
| Pretax Income | $-142M | $-156M | $-195M | $-147M | |
| Income Tax | $1M | $166.0K | $39M | $227.0K | |
| Net Income | $-143M | $-158M | $-240M | $-157M | |
| EPS (Basic) | $-1.12 | $-1.62 | $-2.94 | $-2.01 | |
| EPS (Diluted) | $-1.12 | $-1.62 | $-2.94 | $-2.01 | |
| Shares (Basic) | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | |
| Shares (Diluted) | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | |
| EBITDA | $-121M | $-131M | $-166M | $-124M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $261M | $251M | $279M | $326M | |
| Receivables | · | · | · | $73M | |
| Inventory | $4M | $2M | $16M | $12M | |
| Prepaid Expense | $6M | $8M | $10M | $23M | |
| Other Current Assets | $6M | $9M | $6M | · | |
| Current Assets | $306M | $291M | $336M | $435M | |
| PP&E (Net) | $0 | $5M | $6M | $3M | |
| PP&E (Gross) | $1M | $10M | $10M | $7M | |
| Accum. Depreciation | $1M | $5M | $4M | $3M | |
| Intangibles | · | · | · | $14M | |
| Other Non-current Assets | $1M | $1M | $711.0K | $902.0K | |
| Total Assets | $323M | $322M | $355M | $491M | |
| Accounts Payable | $9M | $18M | $16M | $12M | |
| Accrued Liabilities | $58M | $62M | $52M | $68M | |
| Current Liabilities | $70M | $80M | $68M | $82M | |
| Capital Leases | $1M | $8M | $10M | $7M | |
| Deferred Tax | $789.0K | $2M | $1M | $4M | |
| Other Non-current Liabilities | $3M | $2M | $9M | $838.0K | |
| Total Liabilities | $509M | $525M | $503M | $411M | |
| Total Debt | $3M | · | · | · | |
| Common Stock | $11M | $8M | $7M | $7M | |
| Paid-in Capital | $1.44B | $1.28B | $1.18B | $1.17B | |
| Retained Earnings | $-1.64B | $-1.49B | $-1.34B | $-1.10B | |
| Treasury Stock | $205.0K | $220.0K | $541.0K | $679.0K | |
| AOCI | $-517.0K | $-1M | $-93.0K | $2M | |
| Stockholders' Equity | $-186M | $-203M | $-148M | $79M | |
| Liabilities + Equity | $323M | $322M | $355M | $491M | |
| Shares Outstanding | 125,748,762 | 101,606,376 | 89,041,946 | 89,041,946 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $13M | $49M | |
| Deferred Tax | $0 | $0 | $37M | $-2M | |
| Operating Cash Flow | $-141M | $-124M | $-119M | $-138M | |
| CapEx | $264.0K | $867.0K | $3M | $687.0K | |
| Investing Cash Flow | $395.0K | $-867.0K | $-3M | $-687.0K | |
| Stock Issued | $86M | $61M | $0 | · | |
| Net Stock Activity | $86M | $61M | · | · | |
| Financing Cash Flow | $151M | $97M | $74M | $-897.0K | |
| Taxes Paid | $-100.0K | $-900.0K | · | · | |
| Free Cash Flow | $-141M | $-125M | $-122M | $-137M | |
| Levered FCF | · | $-175M | $-177M | $-175M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -149.3% | -184.4% | -238.6% | · | |
| Net Margin | -175.3% | -222.8% | -345.1% | · | |
| Pretax Margin | -174.1% | -220.4% | -280.9% | · | |
| EBITDA Margin | -149.3% | -184.4% | -238.6% | · | |
| ROA | -44.2% | -46.7% | -56.8% | -27.2% | |
| ROE | 74.1% | 84.3% | 225.9% | -128.4% | |
| ROIC | 66.9% | 64.5% | 134.4% | -140.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 4.4 | 3.8 | 5.0 | 4.5 | |
| Quick Ratio | 3.7 | 3.1 | 4.1 | 4.0 | |
| Debt / Equity | -0.0 | · | · | · | |
| Interest Coverage | · | -2.6 | -3.6 | -3.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | · | |
| Inventory Turnover | 1.8 | 0.3 | 0.2 | 0.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $-1.48 | $-2.05 | $-1.80 | · | |
| Revenue / Share | $0.64 | $0.73 | $0.85 | · | |
| Cash Flow / Share | $-1.11 | $-1.27 | $-1.45 | · | |
| Cash / Share | $2.08 | $2.54 | $3.39 | · | |
| EPS (TTM) | $-1.12 | $-1.62 | $-2.94 | $-2.01 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 14.8% | 1.8% | -66.9% | · | |
| Revenue CAGR 3Y | -27.1% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $81M | $71M | $70M | $210M | |
| Net Income TTM | $-143M | $-158M | $-240M | $-157M | |
| Market Cap | $444M | $197M | $137M | · | |
| Enterprise Value | $186M | · | · | · | |
| P/E | -3.2 | -1.2 | -0.6 | -1.9 | |
| P/S | 5.5 | 2.8 | 2.0 | · | |
| P/B | -2.4 | -1.0 | -0.9 | · | |
| P / Cash Flow | -3.1 | -1.6 | -1.2 | · | |
| P / FCF | -3.1 | -1.6 | -1.1 | · | |
| EV / EBITDA | -1.5 | · | · | · | |
| EV / FCF | -1.3 | · | · | · | |
| EV / Revenue | 2.3 | · | · | · | |
| Earnings Yield | -31.7% | -81.4% | -177.1% | -52.3% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $21M | $23M | $16M | $19M | $23M | $17M | $18M | $17M | $18M | $17M | $14M | $19M | $19M | |
| R&D Expense | $17M | $20M | $18M | $27M | $30M | $29M | $27M | $33M | $24M | $26M | $30M | $27M | $31M | $38M | |
| SG&A Expense | $10M | $10M | $9M | $8M | $9M | $10M | $10M | $10M | $10M | $12M | $11M | $10M | $12M | $16M | |
| Operating Expenses | $45M | $46M | $41M | $47M | $63M | $51M | $49M | $54M | $46M | $52M | $57M | $51M | $59M | $69M | |
| Operating Income | $-25M | $-25M | $-18M | $-31M | $-44M | $-28M | $-32M | $-36M | $-29M | $-34M | $-40M | $-36M | $-40M | $-50M | |
| Interest Expense | · | · | · | · | · | $12M | · | $13M | $13M | $12M | $13M | $13M | $10M | $10M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-op | $21M | $3M | $22M | $925.0K | $-182.0K | $203.0K | $11M | $2M | $3M | $-3M | $10M | $860.0K | $-5M | $833.0K | |
| Pretax Income | $-17M | $-33M | $-7M | $-41M | $-55M | $-38M | $-31M | $-44M | $-36M | $-46M | $-40M | $-45M | $-53M | $-57M | |
| Income Tax | $0 | $0 | $-404.0K | $0 | $1M | $165.0K | $-321.0K | $90.0K | $234.0K | $163.0K | $43M | $-85.0K | $-4M | $518.0K | |
| Net Income | $-17M | $-33M | $-6M | $-41M | $-57M | $-39M | $-31M | $-44M | $-37M | $-47M | $-85M | $-47M | $-49M | $-59M | |
| EPS (Basic) | $-0.11 | $-0.21 | $0.04 | $-0.30 | $-0.50 | $-0.36 | $-0.26 | $-0.42 | $-0.38 | $-0.56 | $-1.04 | $-0.57 | $-0.60 | $-0.73 | |
| EPS (Diluted) | $-0.11 | $-0.21 | $0.04 | $-0.30 | $-0.50 | $-0.36 | $-0.26 | $-0.42 | $-0.38 | $-0.56 | $-1.04 | $-0.57 | $-0.60 | $-0.73 | |
| Shares (Basic) | 155,016,023 | 154,142,347 | · | 136,446,534 | 113,743,358 | 107,202,374 | · | 104,824,877 | 95,691,245 | 82,552,322 | · | 82,256,847 | 81,471,127 | 80,805,770 | |
| Shares (Diluted) | 155,016,023 | 154,142,347 | · | 136,446,534 | 113,743,358 | 107,202,374 | · | 104,824,877 | 95,691,245 | 82,552,322 | · | 82,256,847 | 81,471,127 | 80,805,770 | |
| EBITDA | $-25M | $-25M | · | $-31M | $-44M | $-28M | · | $-36M | $-29M | $-34M | · | · | · | · |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $231M | $261M | $235M | $265M | $195M | $251M | $274M | $300M | $234M | $279M | · | · | · | |
| Inventory | $5M | $5M | $4M | $18M | $18M | $17M | $2M | $16M | $15M | $16M | $16M | · | · | · | |
| Prepaid Expense | $5M | $6M | $6M | $6M | $5M | $7M | $8M | $19M | $17M | $17M | $10M | · | · | · | |
| Other Current Assets | $4M | $4M | $6M | $6M | $6M | $7M | $9M | · | · | · | $6M | · | · | · | |
| Current Assets | $262M | $277M | $306M | $287M | $319M | $258M | $291M | $333M | $355M | $290M | $336M | · | · | · | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $5M | $5M | $6M | $5M | $6M | $6M | · | · | · | |
| PP&E (Gross) | · | · | $1M | $6M | $6M | $11M | $10M | $11M | $10M | $10M | $10M | · | · | · | |
| Accum. Depreciation | · | · | $1M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $4M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $986.0K | $711.0K | · | · | · | |
| Total Assets | $279M | $291M | $323M | $290M | $322M | $273M | $322M | $349M | $372M | $308M | $355M | · | · | · | |
| Accounts Payable | $13M | $5M | $9M | $8M | $10M | $16M | $18M | $14M | $11M | $14M | $16M | · | · | · | |
| Accrued Liabilities | $67M | $58M | $58M | $54M | $55M | $42M | $62M | $53M | $47M | $49M | $52M | · | · | · | |
| Current Liabilities | $86M | $68M | $70M | $62M | $65M | $58M | $80M | $68M | $58M | $63M | $68M | · | · | · | |
| Capital Leases | $946.0K | $991.0K | $1M | $1M | $1M | $8M | $8M | $9M | $9M | $10M | $10M | · | · | · | |
| Deferred Tax | · | · | $789.0K | · | · | · | $2M | · | · | · | $1M | · | · | · | |
| Other Non-current Liabilities | $6M | $5M | $3M | $9M | $7M | $4M | $2M | $8M | $7M | $7M | $9M | · | · | · | |
| Total Liabilities | $508M | $508M | $509M | $528M | $521M | $511M | $525M | $521M | $503M | $502M | $503M | · | · | · | |
| Total Debt | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $11M | $11M | $11M | $10M | $10M | $8M | $8M | $8M | $8M | $7M | $7M | · | · | · | |
| Paid-in Capital | $1.45B | $1.44B | $1.44B | $1.38B | $1.38B | $1.29B | $1.28B | $1.28B | $1.28B | $1.18B | $1.18B | · | · | · | |
| Retained Earnings | $-1.69B | $-1.67B | $-1.64B | $-1.63B | $-1.59B | $-1.53B | $-1.49B | $-1.46B | $-1.42B | $-1.38B | $-1.34B | · | · | · | |
| Treasury Stock | $205.0K | $205.0K | $205.0K | $205.0K | $207.0K | $207.0K | $220.0K | $222.0K | $239.0K | $502.0K | $541.0K | · | · | · | |
| AOCI | $-814.0K | $-802.0K | $-517.0K | $-702.0K | $-388.0K | $-1M | $-1M | $203.0K | $-338.0K | $-201.0K | $-93.0K | · | · | · | |
| Stockholders' Equity | $-228M | $-216M | $-186M | $-238M | $-199M | $-238M | $-203M | $-172M | $-132M | $-194M | $-148M | · | · | · | |
| Liabilities + Equity | $279M | $291M | $323M | $290M | $322M | $273M | $322M | $349M | $372M | $308M | $355M | · | · | · | |
| Shares Outstanding | 127,438,173 | 127,165,116 | 125,748,762 | 112,626,731 | 112,499,083 | 99,178,286 | 98,861,402 | 96,687,985 | 96,469,641 | 82,777,226 | 82,293,137 | · | · | · |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $2M | $673.0K | $2M | $2M | $2M | $2M | $3M | $2M | $158.0K | $2M | $2M | $1M | $8M | |
| Operating Cash Flow | $-12M | $-30M | $-31M | $-30M | $-24M | $-56M | $-22M | $-25M | $-33M | $-44M | $-32M | $-37M | $-35M | $-15M | |
| CapEx | $0 | $32.0K | $0 | $0 | $0 | $264.0K | $90.0K | $216.0K | $30.0K | $531.0K | $327.0K | $661.0K | $1M | $1M | |
| Investing Cash Flow | $0 | $-32.0K | $659.0K | $0 | $0 | $-264.0K | $-90.0K | $-216.0K | $-30.0K | $-531.0K | $-327.0K | $-661.0K | $-1M | $-1M | |
| Stock Issued | $0 | $-20.0K | $44M | $-479.0K | $43M | $0 | $0 | $-1M | · | · | $0 | $0 | · | · | |
| Net Stock Activity | · | $-20.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-99.0K | $-583.0K | $57M | $-198.0K | $94M | $271.0K | $-1M | $-879.0K | $99M | $356.0K | $-1.0K | $349.0K | $73M | $425.0K | |
| Free Cash Flow | · | $-30M | · | · | · | $-57M | · | · | · | $-45M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | $-69M | · | · | · | $-57M | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -132.0% | -121.1% | · | -188.5% | -234.3% | -123.6% | · | -192.6% | -166.8% | -186.2% | · | · | · | · | |
| Net Margin | -86.1% | -158.1% | · | -249.4% | -300.7% | -167.6% | · | -238.1% | -209.9% | -258.2% | · | · | · | · | |
| Pretax Margin | -86.1% | -158.1% | · | -249.4% | -294.0% | -166.9% | · | -236.2% | -205.1% | -253.4% | · | · | · | · | |
| EBITDA Margin | -132.0% | -121.1% | · | -188.5% | -234.3% | -123.6% | · | -192.6% | -166.8% | -186.2% | · | · | · | · | |
| ROA | -5.5% | -11.7% | · | -12.8% | -16.3% | -13.3% | · | -25.2% | -19.7% | -30.3% | · | · | · | · | |
| ROE | 7.8% | 14.5% | · | 20.0% | 34.2% | 17.8% | · | 51.1% | 55.5% | 47.9% | · | · | · | · | |
| ROIC | 11.5% | 11.9% | · | 13.0% | 22.7% | 12.0% | · | 20.7% | 22.2% | 17.3% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 4.1 | · | 4.6 | 4.9 | 4.5 | · | 4.9 | 6.2 | 4.6 | · | · | · | · | |
| Quick Ratio | 2.5 | 3.4 | · | 3.8 | 4.1 | 3.4 | · | 4.1 | 5.2 | 3.7 | · | · | · | · | |
| Debt / Equity | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | -2.3 | · | -2.7 | -2.3 | -2.7 | · | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.79 | $-1.70 | · | $-2.11 | $-1.77 | $-2.40 | · | $-1.78 | $-1.36 | $-2.35 | · | · | · | · | |
| Revenue / Share | $0.12 | $0.14 | · | $0.12 | $0.17 | $0.21 | · | $0.18 | $0.18 | $0.22 | · | · | · | · | |
| Cash Flow / Share | · | $-0.19 | · | · | · | $-0.53 | · | · | · | $-0.53 | · | · | · | · | |
| Cash / Share | $1.72 | $1.82 | · | $2.08 | $2.35 | $1.96 | · | $2.84 | $3.11 | $2.83 | · | · | · | · | |
| EPS (TTM) | $-0.58 | $-0.97 | · | $-1.42 | $-1.54 | $-1.42 | · | $-2.40 | $-2.55 | $-2.77 | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $80M | $79M | · | $75M | $77M | $76M | · | $71M | $67M | $69M | · | · | · | · | |
| Net Income TTM | $-97M | $-137M | · | $-167M | $-170M | $-150M | · | $-212M | $-215M | $-227M | · | · | · | · | |
| Market Cap | $136M | $477M | · | $451M | $301M | $140M | · | $305M | $305M | $372M | · | · | · | · | |
| Enterprise Value | $-77M | $250M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -3.9 | · | -2.8 | -1.7 | -1.0 | · | -1.3 | -1.2 | -1.6 | · | · | · | · | |
| P/S | 1.7 | 6.0 | · | 6.0 | 3.9 | 1.8 | · | 4.3 | 4.6 | 5.4 | · | · | · | · | |
| P/B | -0.6 | -2.2 | · | -1.9 | -1.5 | -0.6 | · | -1.8 | -2.3 | -1.9 | · | · | · | · | |
| P / Cash Flow | · | -16.1 | · | · | · | -2.5 | · | · | · | -8.4 | · | · | · | · | |
| EV / Revenue | -1.0 | 3.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -54.2% | -25.9% | · | -35.5% | -57.5% | -100.7% | · | -76.2% | -80.7% | -61.7% | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $81M | $71M | $70M | $210M | · |
| Betriebsgewinnmarge % | -149.3% | -184.4% | -238.6% | · | · |
| Nettoergebnis | $-143M | $-158M | $-240M | $-157M | $-230M |
| Verwässerte EPS | $-1.12 | $-1.62 | $-2.94 | $-2.01 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -0.0 | · | · | · | · |
| Liquiditätsgrad | 4.4 | 3.8 | 5.0 | 4.5 | 7.1 |
| Quick Ratio | 3.7 | 3.1 | 4.1 | 4.0 | 6.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-141M | $-125M | $-122M | $-137M | $-237M |
Institutionelle Eigentümer (13F) 120 Einreicher · $93.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
120
Gehaltener Wert
$93.2M
Neue Positionen
27
Geschlossene Positionen
30
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (+4 vs. Vorquartal) | 30 (+18 vs. Vorquartal) | 42 (-9 vs. Vorquartal) | 30 (+1 vs. Vorquartal) | -2.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $13.189.017 | 12.326.184 | 14,15% | Aktien |
| Redmile Group, LLC | $12.333.580 | 11.526.710 | 13,23% | Aktien |
| TCG Crossover Management, LLC | $12.187.487 | 11.390.175 | 13,08% | Aktien |
| Prosight Management, LP | $8.372.481 | 7.824.749 | 8,98% | Aktien |
| BlackRock, Inc. | $7.511.500 | 7.020.093 | 8,06% | Aktien |
| VANGUARD GROUP INC | $3.987.442 | 1.129.587 | 4,28% | Aktien |
| Point72 Asset Management, L.P. | $3.904.584 | 3.649.144 | 4,19% | Aktien |
| MORGAN STANLEY | $3.264.755 | 3.051.173 | 3,50% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.102.502 | 2.899.535 | 3,33% | Aktien |
| Vantage Consulting Group Inc | $2.410.983 | 682.998 | 2,59% | Aktien |
| CITADEL ADVISORS LLC | $2.197.048 | 2.053.316 | 2,36% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.048.434 | 1.914.424 | 2,20% | Aktien |
| STATE STREET CORP | $1.803.845 | 1.685.836 | 1,94% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.546.733 | 1.445.546 | 1,66% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.378.381 | 1.288.206 | 1,48% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $959.888 | 897.092 | 1,03% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $827.553 | 773.414 | 0,89% | Aktien |
| Blue Owl Capital Holdings LP | $784.918 | 733.568 | 0,84% | Aktien |
| D. E. Shaw & Co., Inc. | $769.672 | 719.320 | 0,83% | Aktien |
| Opaleye Management Inc. | $749.000 | 700.000 | 0,80% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $704.193 | 658.125 | 0,76% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $698.548 | 652.849 | 0,75% | Aktien |
| NORTHERN TRUST CORP | $635.607 | 594.025 | 0,68% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $622.322 | 581.609 | 0,67% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $612.913 | 572.816 | 0,66% | Aktien |
| UBS Group AG | $556.714 | 520.293 | 0,60% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $431.345 | 418.782 | 0,46% | Aktien |
| TWO SIGMA ADVISERS, LP | $425.602 | 120.567 | 0,46% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $406.763 | 108.470 | 0,44% | Aktien |
| WELLS FARGO & COMPANY/MN | $328.644 | 307.144 | 0,35% | Aktien |
| Russell Investments Group, Ltd. | $306.664 | 286.604 | 0,33% | Aktien |
| Bank of New York Mellon Corp | $269.260 | 251.645 | 0,29% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $250.760 | 234.355 | 0,27% | Aktien |
| Florida Trust Wealth Management Co | $246.565 | 230.435 | 0,26% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $239.742 | 224.058 | 0,26% | Aktien |
| Nuveen, LLC | $189.061 | 176.693 | 0,20% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $171.414 | 160.200 | 0,18% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $160.500 | 150.000 | 0,17% | Kaufoption |
| JPMORGAN CHASE & CO | $157.116 | 152.540 | 0,17% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $151.238 | 141.344 | 0,16% | Aktien |
| XTX Topco Ltd | $150.165 | 140.341 | 0,16% | Aktien |
| FMR LLC | $142.069 | 132.775 | 0,15% | Aktien |
| RHUMBLINE ADVISERS | $125.571 | 117.364 | 0,13% | Aktien |
| Focus Partners Wealth | $119.627 | 111.801 | 0,13% | Aktien |
| Quadrature Capital Ltd | $113.088 | 105.690 | 0,12% | Aktien |
| Revolve Wealth Partners, LLC | $107.000 | 100.000 | 0,11% | Aktien |
| Wilmington Savings Fund Society, FSB | $107.000 | 100.000 | 0,11% | Aktien |
| DLK Investment Management, LLC | $104.770 | 33.155 | 0,11% | Aktien |
| BARCLAYS PLC | $100.864 | 94.264 | 0,11% | Aktien |
| DEUTSCHE BANK AG\ | $89.285 | 83.444 | 0,10% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| A.T. Holdings II Sarl, C.T. Phinco Sarl, ADC Products Switzerland Sarl, Auven Therapeutics Holdings L.P., Auven Therapeutics General L.P., Auven Therapeutics GP Ltd., Stephen Evans-Freke, Peter B. Corr ×8 Einreichungen | 25. April 2024 | · | Erste Einreichung | · | SEC |
| HPWH TH AG, HP WILD HOLDING AG, Dr. Hans-Peter Wild, Thomas Pfisterer | 14. September 2020 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 14 Insider · 5 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ameet Mallik | Chief Executive Officer | 30. Juni 2026 A | 2.121.769 | 0 | 0 | $0 |
| Jose Carmona | Chief Financial Officer | 30. Juni 2026 A | 938.076 | 0 | 0 | $0 |
| Mohamed Zaki | Chief Medical Officer | 30. Juni 2026 A | 896.317 | 0 | 0 | $0 |
| Peter J Graham | Chief Legal Officer | 30. Juni 2026 A | 841.640 | 0 | 0 | $0 |
| Lisa Michelle Kallebo | Chief Accounting Officer | 13. Februar 2026 F | 128.224 | 0 | 0 | $0 |
| Peter Hug | Direktor | 3. Juni 2026 F | 263.344 | 0 | 0 | $0 |
| Viviane Monges | Direktor | 3. Juni 2026 F | 186.447 | 0 | 0 | $0 |
| Robert Azelby | Direktor | 3. Juni 2026 F | 112.805 | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Direktor | 3. Juni 2026 F | 139.302 | 0 | 0 | $0 |
| Victor Sandor | Direktor | 3. Juni 2026 F | 140.686 | 0 | 0 | $0 |
| Ron Squarer | Direktor | 3. Juni 2026 F | 123.431 | 0 | 0 | $0 |
| Timothy Coughlin | Direktor | 3. Juni 2026 F | 72.400 | 0 | 0 | $0 |
| Hans Peter Wild | 10%-Eigentümer | 15. Mai 2025 J | 9.788.944 | 0 | 0 | $0 |
| Thomas Pfisterer | · | 15. Mai 2025 J | 173.899 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 11 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 358.020 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 74.478 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 713.042 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 2.687.086 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 51.103 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 202.930 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 48.185 SH | 3. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 611.978 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 24.289 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.269 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 715.322 SH | 11. September 2026 | Täglich |
ADCT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 12 Analysten
KAUF
Median-Ziel
$3.00
+165,5%
4 33,3%
Starker Kauf
4 33,3%
Kauf
3 25,0%
Halten
0 0,0%
Verkauf
1 8,3%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-10-01Mittelwert-Ziel $3.33 +195,0%
← Unter allen Zielen
Aktueller Preis $1.13
Tief$2.00
Mittelwert$3.33
Hoch$5.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026